As of 20 March 2023, all AstraZeneca COVID-19 vaccine (Vaxzevria) stock available in Australia has expired.  

Any remaining stock should not be administered and should be disposed of according to your state or territory’s requirements. 

Nuvaxovid (Novavax), Spikevax (Moderna) and Comirnaty (Pfizer) remain available for COVID-19 vaccine administration.